Sign in
Taking people in United StatesNo phase

Diet plus home exercise for people with peripheral artery disease and leg pain

Tests the DASH diet added to home exercise in peripheral artery disease.

Key facts

Who runs it
University of Oklahoma
Where
Oklahoma City, United StatesSee the site
Trial code
Registry title
The Effects of Diet and Exercise Interventions in Peripheral Artery Disease
Status
Recruiting
People taking part
150 people, planned
Started
16 Sept 2024
Expected to end
31 May 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • DASH Diet plus Home-Based Exercise
  • Home-Based Exercise
Record updated
17 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with peripheral artery disease (narrowed leg arteries) who get leg pain when walking (claudication). It tests the DASH diet plus home walking against home walking alone.

Age
40 Years and older
Sex
All sexes
Disease stage
Peripheral artery disease with a history of claudication. People with leg pain at rest or tissue loss (Fontaine stage III or IV; Rutherford Grade II or III) cannot join.
Earlier treatment
A past procedure to reopen leg arteries (peripheral revascularization) can count as proof of PAD. People who had such a procedure within one month cannot join. People who started cilostazol or pentoxifylline within three months cannot join.
Biomarker or test result
PAD shown by one of: ABI (ankle-brachial index, a blood pressure ratio) at rest < 0.90; or > 20% drop in ABI after a heel-rise exercise test when resting ABI is normal (> 0.90); or past peripheral revascularization. ABI > 1.40 is not allowed.

Main reasons for not taking part

  • Leg pain at rest or tissue loss due to PAD
  • Active cancer
  • End stage kidney disease (stage 5 chronic kidney disease)
  • Health problems that make exercise unsafe according to the American College of Sports Medicine
  • Memory or thinking problems (mini-mental state examination score < 24)

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • History of claudication,
  • Presence of PAD, defined by meeting at least one of the following criteria (ABI at rest < 0.90, or > 20% decrease in ABI following a heel-rise exercise test in patients with a normal ABI at rest (> 0.90), or history of peripheral revascularization

Who cannot take part

  • use of medications indicated for the treatment of intermittent claudication (cilostazol and pentoxifylline) initiated within three months prior to investigation,
  • peripheral revascularization within one month prior to investigation,
  • absence of PAD, defined by meeting all of the following 3 criteria (ABI at rest > 0.90), < 20% decrease in ABI following a heel-rise exercise test, and no history of peripheral revascularization,
  • active cancer,
  • end stage renal disease defined as stage 5 chronic kidney disease,
  • medical conditions that are contraindicative for exercise according to the American College of Sports Medicine,
  • failure to complete the baseline tests within three weeks
  • non-compressible vessels (ABI > 1.40),
  • rest pain due to PAD (Fontaine stage III; Rutherford Grade II),
  • tissue loss due to PAD (Fontaine stage IV; Rutherford Grade III),
  • cognitive dysfunction (mini-mental state examination score < 24), and

Where in United States

  • O'Donoghue Research Building, University of Oklahoma Health Sciences CenterOklahoma City, United StatesContact: Andrew W Gardner, PhDTaking people

About the trial

What the trial wants to find out

This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the DASH dietary program combined with a home-based exercise program, quantified by a step activity monitor, to improve exercise and vascular outcome measures in patients with PAD.

The 2 groups in the trial

  • DASH Diet plus Home-Based ExerciseTreatment being tested

    The DASH dietary program consists of a diet emphasizing foods rich in fruits, vegetables, whole grains, and low-fat dairy, in which patients record daily servings of fruits and vegetables. The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.

  • Home-Based ExerciseExisting treatment, for comparison

    The home-based exercise program consists of intermittent walking to moderate claudication pain 3 times per week for 3 months in a home-based setting.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effects of Diet and Exercise Interventions in Peripheral Artery Disease
Plain-language title
Diet plus home exercise for people with peripheral artery disease and leg painGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
17 April 2026